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AU-rich elements (AREs), present in mRNA
30-UTRs, are potent posttranscriptional regula-
tory signals that can rapidly effect changes in
mRNA stability and translation, thereby dramat-
ically altering gene expression with clinical and
developmental consequences. In human cell
lines, the TNFa ARE enhances translation
relative to mRNA levels upon serum starvation,
which induces cell-cycle arrest. An in vivo
crosslinking-coupled affinity purification meth-
od was developed to isolate ARE-associated
complexes from activated versus basal
translation conditions. We surprisingly found
two microRNP-related proteins, fragile-X-
mental-retardation-related protein 1 (FXR1)
and Argonaute 2 (AGO2), that associate with
the ARE exclusively during translation activa-
tion. Through tethering and shRNA-knockdown
experiments, we provide direct evidence for the
translation activation function of both FXR1 and
AGO2 and demonstrate their interdependence
for upregulation. This novel cell-growth-depen-
dent translation activation role for FXR1 and
AGO2 allows new insights into ARE-mediated
signaling and connects two important post-
transcriptional regulatory systems in an un-
expected way.
INTRODUCTION
Posttranscriptional modulation of gene expression in the
cytoplasm involves RNA sequences that collaborate with
trans-acting factors to regulate mRNA localization, trans-
lation, and stability (Valencia-Sanchez et al., 2006; Gray
and Wickens, 1998). The AU-rich element (ARE) is
a well-studied signal present in the 30-UTR of many clini-
cally relevant messages, including those of cytokines, on-
cogenes, and growth factors, whose deregulation canClead to immune disorders and cancer (Balkwill, 2002;
Wilusz et al., 2001; Brewer, 2002). AREs are best known
as decay elements (Wilusz et al., 2001; Bakheet et al.,
2001), but they also regulate translation and mRNA export
(Espel, 2005; Kontoyiannis et al., 1999).
The cytokine tumor necrosis factor a (TNFa), which is
normally expressed in stimulated lymphocytes, is critical
for inflammatory responses and malignancies (Balkwill,
2002). When circulating monocytes become adherent
during the process of extravasation into inflamed tissues
or in proangiogenic tumor infiltration, cell growth arrests
with rapid changes in cytokine expression (Haskill et al.,
1988), including that of TNFa, which further upregulates
other cytokines necessary for maturation into macro-
phages (Jeoung et al., 1995; Moneo et al., 2003; Pomorski
et al., 2004). This response can be recapitulated in cell cul-
ture by serum starvation (Haskill et al., 1988; Sirenko et al.,
1997).
The 30-UTR of TNFa mRNA is highly conserved among
mammals with several important posttranscriptional regu-
latory elements, including a 34 nt ARE (Figure 1A). In mice,
deletion of the TNFa ARE results in misregulated TNFa
translation in macrophages, monocytes, and neutrophils
(Kontoyiannis et al., 1999). In vitro, monocytic cell lines
such as THP-1 respond to phorbol esters to regulate
TNFa translation or to lipopolysaccharide (LPS) to regulate
TNFa mRNA stability, both of which are mediated by the
ARE (Andersson and Sundler, 2000; Brooks et al., 2004).
ARE-binding proteins affect mRNA stability, but their
contributions to translation control remain less well under-
stood (Wilusz et al., 2001; Stoecklin et al., 2000; Brewer,
2002). Factors that bind the TNFa and other AREs in re-
sponse to signaling pathways and that affect stability or
translation include HuR (Brennan and Steitz, 2001;
Mazan-Mamczarz et al., 2003), the Tristetraprolin (TTP)
family of proteins (Carballo et al., 1998; Stoecklin et al.,
2000), and FXR1. FXR1 exists as seven spliced isoforms
that are highly conserved in mammals (Kirkpatrick et al.,
1999, 2001) and that are associated with microRNAs
and the RNAi machinery in both Drosophila (Caudy
et al., 2002) and HeLa cells (Jin et al., 2004). FXR1 knock-
out and conditional knockout mice exhibit muscle wast-
ing, decreased growth rate, and neonatal death withell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc. 1105
Figure 1. In Vivo Assay for ARE-Regulated Translation
(A) TNFa mRNA with conserved regions, including a splicing regulator (APRE; Osman et al., 1999), the ARE (AU), and a constitutive decay element
(CDE; Stoecklin et al., 2003) are shown. Firefly luciferase reporter constructs with the 34 nt TNFa ARE (ARE), the 795 nt TNFa 30-UTR (UTR), the 34 nt
mutant ARE (mt ARE), or a 34 nt vector sequence (CTRL) were cotransfected with aRenilla luciferase reporter (REN). Mutations in mt ARE and regions
protected by the probes used in RNase protection assays (RPAs) are underlined.
(B) HEK293 cells were transfectedwith the ARE andREN reporters and 18 hr later were switched to serum-containing (+) or serum-lacking () medium
containing either TPA/Io (see Experimental Procedures) or the DMSO solvent. Eighteen hours later, firefly and Renilla luciferase activities were as-
sayed. The values in panels (B), (D), and (E) are averages from at least three transfections ± SD.
(C) Northern blots show ARE- and REN-reporter levels in ± serum, with TPA/Io, Io alone, and/or the solvent DMSO as indicated. Table S2 shows the
RNA values.
(D) Luciferase values (B) were normalized to the mRNA levels (C) to obtain translation efficiencies (defined in Figure 1A; see Figure S1 and Tables S1
and S2). Since similar changes upon serum starvation without TPA/Io were observed without normalizing for RNA levels (B), normalization does not
artificially produce an apparent increase in translation.
(E) Comparison of translation efficiencies of the ARE and UTR reporters relative to the control reporters, CTRL, and mt ARE in response to the pres-
ence or absence of serum without DMSO is shown.1106 Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc.
translational upregulation of proinflammatory cytokines
such as TNFa (Mientjes et al., 2004; Garnon et al., 2005).
Several studies suggest the involvement of microRNPs
as regulators of ARE-bearing mRNAs. First, RNA-induced
silencing complex (RISC), the functional microRNP, in-
cludes two ARE-associated proteins: PAI-RBP1 and
FXR1 (Caudy et al., 2002); FXR1 interacts via Argonaute
2 (AGO2; Jin et al., 2004; Xu et al., 2004). AGO2 is the es-
sential functional effector of the microRNP—the slicer in
microRNA-mediated decay (Meister et al., 2004; Liu
et al., 2004) or the repressor in microRNA-mediated trans-
lational repression (Pillai et al., 2004). Second, microRNAs
have been localized to the same cytoplasmic bodies
(Jakymiw et al., 2005; Liu et al., 2005a; Pillai et al., 2005)
as ARE-binding proteins (Kedersha et al., 2005; Stoecklin
et al., 2004). Third, miR16-1 regulates the level of a
TNFa 30-UTR-containing reporter RNA through TTP,
which also interacts with RISC via AGO2 (Jing et al., 2005).
The goal of this study was to establish an in vivo system
to study TNFa-ARE-mediated translation control and to
determine the molecular nature of the ARE-associated
regulators. We first show that the TNFa ARE upregulates
translation in response to cell-cycle arrest in HEK293 cells
and in THP-1 monocytes when induced by serum starva-
tion or other treatments. This upregulation is physiologi-
cally relevant since cell-cycle arrest accompanies the dif-
ferentiation of monocytes into macrophages in vivo. We
then developed an affinity-purification scheme to isolate
in vivo ARE-associated complexes from various transla-
tion conditions. Surprisingly, we find that FXR1 and AGO2,
which previously were considered effectors of translation
repression, associate with TNFa ARE and function as
translation activators in response to serum starvation.
RESULTS
An In Vivo Assay for Translation Regulation
by the TNFa ARE
We constructed firefly luciferase reporters containing
either the minimal TNFa ARE (34 nt; ARE in Figure 1A) or
the entire 30-UTR (795 nt; UTR, Figure 1A) and transfected
them into HEK293 and monocytic THP-1 cells. In all lucif-
erase assays, the following controls were included: a co-
transfected Renilla reporter bearing a vector sequence in
its 30-UTR (REN, Figure 1A) to normalize for extract con-
centrations, transfection efficiency, and overall translation
status and a firefly luciferase construct with either a mu-
tated ARE (mt ARE, Figure 1A) or vector sequence of the
same size (CTRL, Figure 1A). To distinguish translational
output from mRNA turnover, most luciferase assays were
normalized to luciferase-reporter RNA levels to obtain
the translation efficiency (defined in Figures 1A and S1).
The TNFa ARE Regulates Translation in Response
to Serum
Translational upregulation of TNFa had previously been
observed in response to phorbol esters (Andersson and
Sundler, 2000; Garnon et al., 2005). The above reportersCwere therefore tested for luciferase expression after treat-
ment with 12-O-tetradecanoyl-phorbol-13-acetate (TPA)
and Ionomycin (Io) in serum-grown, as well as serum-
starved cells (to avoid inhibitors potentially present in
serum).
When HEK293 cells previously transfected with the ARE
reporter were grown without TPA/Io in serum-containing
media, a low basal level of translation (Figure 1B) as well
as a low level of the reporter RNA (Figure 1C, lanes 1
and 2) were observed. However, after 18 hr in serum-
starved conditions, firefly luciferase activity increased
8-fold (Figure 1B) without a corresponding increase in
RNA levels (Figure 1C, lanes 5 and 6; see Table S2 for
quantitation of the RNA levels) or in the Renilla values
used for normalization (Figure S1, compare graphs A
and B; Tables S1 and S2). In contrast, as previously noted
by Stoecklin et al. (2003), in the presence of TPA/Io with or
without serum, the TNFa-ARE-reporter RNA level in-
creased at least 10-fold (Figure 1C, lanes 4 and 8). Thus,
the drug-induced increase in translation (Figure 1B) re-
flects mostly stabilization of the mRNA rather than a true
translation effect.
Consequently, two translation conditions without TPA/
Io (and its DMSO solvent) were chosen for all further stud-
ies, and luciferase values were normalized to RNA levels
(Figures 1D and S1). (1) In serum-growth conditions, basal
translation reflects low mRNA levels. (2) In serum-starved
conditions, translation is enhanced without a significant
change in mRNA levels, indicating translation activation.
Similar results were obtained with the ARE reporter in
monocytic THP-1 cells (not shown) and with the 30-UTR
reporter (UTR, Figure 1E), which confirms that the activity
of the TNFa ARE is the same in its natural cellular and mo-
lecular contexts. Importantly, the translation efficiency of
the mt ARE reporter was unchanged between serum-
grown and -starved conditions (Figure 1E) even though
its RNA abundance was higher than the ARE reporter
(Figure S2). Thus, an intact TNFa ARE bears sufficient in-
formation to execute regulated translation, and mutating
the ARE results in a loss of translation control.
Cell-Cycle Arrest Causes TNFa ARE
Translation Upregulation
Serum-responsive translation regulation could result from
direct effects of serum deprivation or from serum-starva-
tion-induced cell-cycle arrest. We manipulated the cell
cycle in ways that avoided removal of serum. First, aphidi-
colin, a G1/S phase inhibitory drug that induces growth ar-
rest (Jeoung et al., 1995), was added to actively growing
HEK293 cells transfected with our reporter constructs
for 36 hr. A 3- to 5-fold increase in the translation efficiency
of the ARE and UTR reporters, but not of the mt ARE re-
porter, resulted (compare Figures 2A and 1E). Second,
we allowed the cells to grow to saturation, whereupon
they arrested the cell cycle (Boonstra, 2003); then, the
growth-arrested cells were either maintained or replated
in fresh media to induce cell-cycle progression. The ar-
rested cells exhibited a 3- to 5-fold increase in translationell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc. 1107
efficiency of the ARE andUTR reporters compared to both
the mt ARE reporter and the same reporters in cycling
cells (compare Figure 2B to Figures 1E and 2A; Table S3
shows the raw numbers). In these two situations, as well
as in serum-starved cells, western blots that were probed
for Ki67, a cell-cycle marker, revealed the expected de-
creased level (Figure S3A; Schafer, 1998). Translation ac-
tivation upon G1/G0 growth arrest (Figures 1, 2, and S3A)
and not G2 arrest (Figure S3B) indicates that the TNFa
ARE responds to specific cell-cycle cues.
Isolation of ARE-Associated, Translation-Activating,
and Basal Translation Complexes
The next step was to compare the composition of the se-
rum-regulated ARE-associated complexes. There are at
least two major problems. First, AREs are dynamically
bound by factors, some with very rapid off rates that
lead to loss upon purification (Park-Lee et al., 2003). Sec-
ond, during cell-extract preparation, abundant nonspe-
cific RNA-binding proteins can compete off the limiting,
endogenous ARE-bound proteins (Mili and Steitz, 2004).
Therefore, we used in vivo formaldehyde crosslinking to
‘‘freeze’’ ARE-associatedmRNPcomplexes (Niranjanaku-
mari et al., 2002). Purification of the extracts on streptavi-
din beads then selected only S1-aptamer-tagged mRNPs
(Srisawat and Engelke, 2002; Figure 3A). After reversal of
the formaldehyde crosslinks, RNA components of the com-
plexes were examined by RNase protection (Figure 3B),
Figure 2. Cell-Cycle Arrest Increases Translation Mediated
by the TNFa ARE
(A) Eighteen hours after transfection as in Figure 1, HEK293 cells were
treated with aphidicolin dissolved in DMSO or with DMSO alone for
36 hr before measuring luciferase activities and mRNA levels by RPA.
The values in panels (A) and (B) are averages from at least three trans-
fections ± SD.
(B) After transfection, cells were grown for 66 hr to saturation. Then,
one set was replated in fresh media; six hours later, luciferase and
mRNA levels were assessed. Cell-cycle arrest was validated by
western blotting for Ki67 (Figure S3 and Table S3).1108 Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Incwhile proteins were identified by mass spectrometry (Fig-
ure S4B; Table S4) and western blotting (Figure 3C).
This strategy was applied to both translation conditions
for the TNFa ARE and UTR reporters after we confirmed
that aptamer tagging did not alter the regulated translation
exhibited by untagged reporters in Figures 1, 2, andS4A.
Figure 3B shows recovery of about 20% of the aptamer-
bearing ARE reporter in the initial HEK293 cell extract in
the biotin eluate from the streptavidin beads, whereas un-
tagged reporters and the cotransfected Renilla (untagged)
RNA were not selected. Experiments without formalde-
hyde crosslinking or with the aptamer-tagged CTRL re-
porter detected nonspecific proteins (Figure S4B).
FXR1 Solubility and mRNA Association
Are Regulated by Serum
Western blot analyses revealed the selective enrichment
of ARE-binding proteins HuR and TTP in mRNPs formed
under both serum conditions on the ARE and UTR com-
pared to CTRL reporters (Figure 3C). In addition, we
detected a 65 kDa isoform (a or b in Figure S5A) of
FXR1, a recently identified TNFa-ARE-binding and puta-
tive translation factor (Garnon et al., 2005), exclusively in
ARE-specific complexes (on the ARE or UTR reporter) in
cells that had been subjected to serum starvation (Fig-
ure 3C). FXR1 was also present in ARE mRNPs that had
been isolated from THP-1 monocytes (data not shown).
Moreover, antibodies against FXR1 coimmunoprecipi-
tated endogenous TNFamRNA from crosslinked extracts
of monocytes that had been cultured under serum-
starved, but not serum-grown, conditions, as revealed
by RT-PCR using three primer sets (Figure S6A). Thus,
the endogenous TNFa mRNP complex contains FXR1 in
a serum-regulated manner identical to our reporters in
HEK293 cells.
The presence of FXR1 in the ARE mRNP could reflect
serum regulation of its cellular levels. Western blotting re-
vealedmultiple isoforms (due to either splicing or modifica-
tion) of FXR1 in soluble extracts of HEK293 cells, but only
when serum starved (Figure 4A, lane 6 versus lane 5). Yet,
FXR1was equally abundant in sonicated whole-cell lysates
from serum-grown or -starved conditions (Figure 4A, lower
panel), which suggests an alteration in solubility rather than
expression. Similar regulation of solubility was previously
reported for an FXR1 isoform during muscle differentiation,
a process mimicked by serum starvation (Mazroui et al.,
2002; Hofmann et al., 2006; Dube et al., 2000).
FXR1 Functions as a Translation Activator
To ask whether FXR1 is essential for translation activation
under serum-starvation conditions, we designed two
shRNAs (Figure S5A). shRNA FA4 (but not shRNA FA3)
knocked down the multiple FXR1 isoforms in serum-
starved HEK293 soluble cell extracts by over 75% (arrow
in Figure 4A), which suggests that the predominant form
present in our cells is FXR1 iso-a. This produced a loss
of translation activation of the ARE reporter, while the
translation efficiency of the CTRL reporter was unaffected.
Figure 3. Purification of mRNP Complexes
(A) After in vivo formaldehyde crosslinking, the S1-tagged ARE construct was purified as described in Experimental Procedures. An S1-tagged CTRL
construct, an untagged ARE reporter, and uncrosslinked controls were examined in parallel.
(B) RPA demonstrates enrichment of the ARE and CTRL S1-tagged RNAs (lanes 9–12) in the biotin eluates compared to the nontagged ARE reporter
(lanes 7 and 8) and the cotransfected REN internal control. Unmarked bands are heat-induced degradation products of the firefly ARE reporter.
Crosslink (uncrosslinked extract) and Extract (no sample) served as RPA controls.
(C) Proteins present in crosslinked eluates from the S1-taggedUTR, ARE, andCTRL constructs in the basal translation serum-grown conditions (lanes
1, 3, and 5) were compared to those in the activated serum-starved conditions (lanes 2, 4, and 6) by western blot analysis. a-UPF3 served as control.
The unlabeled lane between lanes 2 and 3 was from a TPA-treated UTR sample.(Figure 4B). Importantly, this effect was rescued by exog-
enous expression of FXR1 from a clone bearing silent
mutations at the shRNA target site (Figure S5B).
Conversely, exogenous expression of FXR1 iso-a (Fig-
ure 4C) stimulated translation of both the ARE and UTR
reporters compared to mt ARE, but in serum-grown
conditions. This unexpected result correlates with the
increased levels of soluble FXR1 upon exogenous expres-
sion in serum-grown cells (Figure 4C, lower panel). Sincesoluble FXR1 is already abundant in serum-starved cells,
perhaps exogenous expression cannot further enhance
translation.
To confirm translation stimulation by FXR1, FXR1 iso-
a was fused to a lN peptide to anchor it to the 5B Box
luciferase reporter (Figure 4D; Baron-Benhamou et al.,
2004); a Flag tag distinguished the lN-fused from endog-
enous FXR1. Coexpressing the doubly tagged FXR1 iso-
a yielded over a 4-fold increase in translation efficiencyCell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc. 1109
Figure 4. FXR1 Is Required for TNFa-ARE-Mediated Translation Upregulation in Response to Serum Starvation
(A) Knockdown of FXR1 by shRNA FA4, predicted to target FXR1 iso-a (see Figure S5A), is shown. Western blotting (a-FXR1; described in Jin et al.,
2004) reveals FXR1 in the soluble fraction only in serum-starved conditions (upper panel, lanes 1–4, 6, and 8) compared to sonicated total extracts
from the same cells (lower panel). Two-fold titrations of the serum-starved extract (lanes 1–4) are compared with extracts (the same amount as in lane
4) from cells grown with serum (+ lanes) or without serum ( lanes) that were either untreated (lanes 5 and 6) or exposed to either shRNA FA3 (lanes 7
and 8) or shRNA FA4 (lanes 9 and 10). NS is a nonspecific band or breakdown product recognized by the anti-FXR1 polyclonal antibody.
(B) Knockdown of FXR1 by shRNA FA4 leads to loss of translation activation of the ARE relative to the CTRL reporter in serum-starved conditions. The
values in panels (B), (C), and (E) are averages from at least three transfections ± SD.
(C) Exogenous expression of the isoform, FXR1 iso-a (the most abundant isoform in our cells), increases the translation efficiency of the ARE and UTR
reporters but not of the mt ARE in serum-grown conditions. Western blotting (below) demonstrates that exogenous expression of iso-a generates
FXR1 in the soluble fraction of serum-grown cells (+ lanes). The band at 50 kDa is nonspecific and is described in (A). Anti-tubulin provided a loading
control.
(D) The 5B Box tethering site of 343 nt (Baron-Benhamou et al., 2004) replaces the ARE in the firefly ARE reporter.
(E) Flag-tagged FXR1 iso-a tethered by the lN peptide to the 5B Box reporter activates translation in both serum conditions compared to the CTRL
reporter or the empty lN vector.
(F) Western blotting as in (C) reveals similar expression of the lN-peptide- and Flag-tagged FXR1 iso-a in soluble extracts from serum-grown and
-starved cells. The middle panel discriminates the Flag-tagged and endogenous FXR1 isoforms. Comparable results were obtained with cells grown
to saturation (quiescence).1110 Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc.
Figure 5. AGO2 Is Present in the ARE Translation Activation Complex
(A) FXR1 interacts with AGO2 in serum-grown and -starved HEK293 cells. In vivo formaldehyde crosslinking of cells that were untransfected or trans-
fected with the lN-FXR1 iso-a-Flag vector was followed by sonicated cell-extract preparation. Immunoprecipitation of the untransfected sample
(lanes 3–8) with a-FXR1 (lanes 5–8) and of the lN-FXR1 iso-a-Flag-transfected sample (lanes 1, 2, and 9–14) with either a-Flag (lanes 9–12) or
a-HA (lanes 13 and 14, negative control) was followed by stringent washing. Western blotting (a-AGO2 antibody; Upstate) revealed AGO2 coimmu-
noprecipitation with a-FXR1 (lanes 5 and 6) or a-Flag (lanes 9 and 10) from crosslinked samples only (lanes 7 and 8 for a-FXR1 IP and lanes 11 and 12
for a-Flag IP-uncrosslinked). The absence of reporters (this Figure) or the presence of ARE, 5B Box, or control reporters did not alter the interaction
(data not shown). No RNase (this Figure) or RNase-treated extracts (RNase A and RNase One, data not shown) showed similar interactions.
(B) Confocal immunofluorescence imaging was performed with fixed samples of serum-grown and -starved HEK293 cells stained with a-AGO2,
a-FXR1, or a-GW182. TO-PRO-3 (Invitrogen) identified DNA in the nuclei. FXR1 staining was identical using polyclonal antibody from S. Warren
or monoclonal antibody (6GB10) from G. Dreyfuss. Standard controls using single antibodies and no primary antibody ensured no artifactual channel
overlap/staining (data not shown). Magnified images and details are in Figures S7–S8.
(C) RNPs formed on the S1-tagged ARE and CTRL reporters were isolated as in Figure 3A, which was followed by western analysis of the eluates
(lanes 3–8) with a-AGO2. AGO2 appeared specifically in translation activation conditions (compare lanes 5 [serum +] and 7 [serum ]). The extracts
(input) from noncrosslinked cells serve as negative controls (lanes 6 and 8), as do eluates from the S1-tagged CTRL reporter (lanes 3 and 4).
(D) Anti-AGO2 immunoprecipitates the S1-tagged ARE reporter exclusively from translation activation (serum-starved) conditions (lane 4 versus lane
3). Immunoprecipitation was performed as in (A) on extracts of crosslinked cells. The immunoprecipitates (lanes 1–6) and inputs (extracts, lanes 7–12)
were analyzed by RPA. Cells expressing the CTRL (lanes 1 and 2) reporter served as a negative control.for the 5B Box reporter compared to the lN vector in
both serum-starved and -grown cells (Figure 4E). The
lN-tagged FXR1 was equally expressed in soluble ex-
tracts in both conditions (Figure 4F). The CTRL reporter
was unresponsive to the presence of the lN-tagged FXR1,
and cotransfection did not alter RNA levels (Figure S5C).
These results confirm a translation upregulatory activity
for FXR1 iso-a.
FXR1 Interacts with the MicroRNP Factor, AGO2,
under Both Translation Conditions
Drosophila dFMR1 interacts with dAGO1 genetically (Jin
et al., 2004) and with dAGO2 biochemically (Caudy
et al., 2002; Ishizuka et al., 2002), while interactions with
human FXR1 protein have been reported for hAGO1 andChAGO2 (Jin et al., 2004). We therefore asked whether
FXR1 and AGO2 proteins interact in vivo in activated
versus basal translation conditions. Strikingly, 30% of
AGO2was recovered in stringently washed a-FXR1 immu-
noprecipitates from sonicated extracts of cells grown
under both serum conditions after formaldehyde cross-
linking (Figure 5A, lanes 5 and 6 versus 7 and 8). The inter-
action was reproducible with RNase (data not shown) and
in soluble extracts of serum-starved cells, while in serum-
grown soluble extracts FXR1 is discarded during clarifi-
cation (see Figure 4A), thereby precluding interaction
analysis. Additionally, the lN-tagged FXR1 iso-a, which
activated translation when tethered to a reporter (Fig-
ure 4D), coimmunoprecipitated endogenous AGO2 (Fig-
ure 5A, lanes 9 and 10), arguing that the lN tag does notell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc. 1111
interfere with the protein’s normal associations. These re-
sults indicate that FXR1 and AGO2 associate with each
other under both serum-grown and -starved conditions.
Subcellular Colocalization of FXR1 and AGO2
AGO2 is known to localize to P bodies (Liu et al., 2005a),
GW bodies (Jakymiw et al., 2005), and stress granules
(Leung et al., 2006), which are cytoplasmic granules asso-
ciated with translation silencing and mRNA decay. FXR1
has also been reported in cytoplasmic granules (Mazroui
et al., 2002; Hofmann et al., 2006). To ask whether these
are the same bodies, we performed immunofluorescence
studies with antibodies to AGO2 and to FXR1 (Figures 5B,
S7, and S8). A significant fraction of FXR1 and AGO2 ap-
peared in the same or closely associated foci in HEK293
cells in the translationally basal serum-grown conditions
(Figures 5B, top panels, and S7A–S7C). These particular
bodies did not colocalize with hDCP1A (Figures S7F and
S7G), a P-body marker (Kedersha et al., 2005; Andrei
et al., 2005); this is consistent with recent reports that
only up to 1.3% of AGO2 is present in P bodies (Leung
et al., 2006). Interestingly, the FXR1/AGO2 bodies do par-
tially colocalize with GW182 (Figures 5B, lower panels,
and S8A–S8D), a protein previously reported to interact
with AGO2 (Jakymiw et al., 2005; Liu et al., 2005b). GW
bodies are cell-cycle regulated, and they grow in size
and number through the cell cycle but disappear upon mi-
tosis or in quiescent or growth-arrest conditions (Yang
et al., 2004; Lian et al., 2006).
In contrast, in serum-starved cells, FXR1 and AGO2
were diffusely distributed throughout the cytoplasm or ap-
peared in very small bodies (Figures 5B, serum, S7D,
and S7E), while the P-body marker hDCP1A remained in
large bodies (Figure S7G). The disappearance of these
distinct FXR1/AGO2 bodies that partially overlap with
GW bodies interestingly coincides with translation activa-
tion. The absence of discrete bodies and the diffuse cyto-
plasmic colocalization of FXR1 and AGO2 under serum-
starved conditions may be important for ARE-directed
translation upregulation.
AGO2 Is a Component of the TNFa ARE-RNP
in Serum-Starved Conditions
Interaction and cytoplasmic colocalization of FXR1 and
AGO2 suggested that AGO2 may be present not only in
microRNPs (Valencia-Sanchez et al., 2006) but also in
the TNFa ARE-mRNP under translation activation condi-
tions. We used western analysis to probe for AGO2 in
the S1 aptamer-purified in vivo crosslinked complexes
from serum-grown and -starved cells (Figure 5C). Signifi-
cantly, AGO2 was present in the ARE complex exclusively
from serum-starved conditions (lane 7). RNPs that formed
on the CTRL mRNA did not contain AGO2 (lanes 3 and 4),
nor did the ARE mRNPs that were isolated from serum-
grown cells (lane 5) or without crosslinking (lane 8).
Specific association of AGO2 with the TNFa ARE-RNP
was confirmed by anti-AGO2 coimmunoprecipitation of
the TNFa ARE reporter from serum-starved, but not from1112 Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc.serum-grown, cell extracts (Figure 5D, lane 4 versus
lane 3). The CTRL (non-ARE-containing) reporter (lanes 1
and 2) was not precipitated. Furthermore, anti-AGO2
coimmunoprecipitated the endogenous TNFa mRNA
from crosslinked extracts of monocytes grown under
serum-starved (but not serum-grown) conditions, as ana-
lyzed by RT-PCR using three primer sets (Figure S6B).
Together, these results argue for a role for AGO2 in
ARE-directed translation activation.
AGO2 Is a Translation Activator
in Serum-Starved Conditions
To test whether AGO2 has a direct serum-starvation-
specific role in translation upregulation, we tethered
AGO2 via a fused lN peptide to the luciferase reporter
containing 5BBoxes (see Figure 4D). Assays of translation
efficiency in both serum-grown and -starved conditions
revealed a 5-fold upregulation of translation (Figure 6A)
in only serum-starved cells, which is consistent with
AGO2’s interaction with FXR1 (Figure 5A). In contrast, in
serum-grown cells, tethering AGO2 produced a moderate
1.8-fold repression, as previously reported (Liu et al.,
2005b; Pillai et al., 2004). Tethering amutant AGO2protein
(mt AGO2), which is unable to effect translation repression
(Pillai et al., 2004), did not increase translation efficiency
(Figure 6A). RNase-protection analyses demonstrated
that the reporter RNA levels were unchanged (Figure S5C;
Pillai et al., 2004). We conclude that AGO2 functions as
a translation activator in response to serum starvation,
mediating translation upregulation when tethered to an
mRNA reporter.
ToconfirmthatAGO2 isessential for translationactivation
via the TNFa ARE, we performed shRNA knockdown of
AGO2 followed by luciferase assays with our ARE reporters
in serum-grown and -starved conditions. AGO2 levels do
not change with serum conditions and, unlike FXR1 levels,
are similar in sonicated and gently clarified soluble extracts
(Figure 6B), although we do centrifuge out a considerable
amount when preparing polysome extracts (Figure 7B).
Upon partial reduction of AGO2 levels with shAGO2
(Figure 6B), 5-fold lower translation efficiencywas observed
for the TNFa ARE reporter (Figure 6C). Loss of translation
stimulation was similar for the ARE and UTR reporters
(data not shown), which suggests that the TNFa AREmedi-
ates AGO2 recruitment to the 30-UTR and that AGO2 is
essential for translation upregulation.
To determine whether an interaction between FXR1
and AGO2 is necessary for serum-starvation-regulated
translation activation by tethered AGO2, we first per-
formed the AGO2-tethering experiment in an FXR1 knock-
down background. If FXR1 recruits AGO2 directly or indi-
rectly to the ARE-containing message, then the tethered
AGO2 should exhibit serum-starvation-regulated transla-
tion activation even in the absence of FXR1. However,
as shown in Figure 6D, 75% knockdown of FXR1 (data
not shown) led to a loss of translation activation by teth-
ered AGO2 under serum-starvation conditions, which in-
dicates either that interaction between FXR1 and AGO2
Figure 6. AGO2 Activates Translation Mediated by TNFa ARE in Response to Serum Starvation and Requires FXR1 to Function as
a Translation Activator
(A) Tethering AGO2 upregulates translation in response to serum starvation. A mutant form of AGO2 (mt AGO2; Pillai et al., 2004) and the CTRL re-
porter (Figure 1A) without the 5B Boxes provided negative controls. FXR1 iso-a (Figure 4E) served as a positive control. The values in panels (A), (C),
(D), and (E) are averages from at least three transfections ± SD.
(B)Western blot done using a-AGO2of soluble HEK293 extracts to assess knockdown by two shRNAs used together at either 0.5 mg or 1.0 mg plasmid
DNA (shAGO2; see Experimental Procedures) is shown. Two extract concentrations and a-tubulin antibody provided controls.
(C) Comparison of the effects of no shRNA (), FXR1 shRNA (FA4), or AGO2 shRNA (shAGO2) on the translation efficiencies of the ARE and mt ARE
reporters under serum+ and serum conditions shows that both FXR1 and AGO2 are required for upregulation.
(D) FXR1 is essential for translation upregulation mediated by tethered AGO2. AGO2 or the lN-tag vector (as a control) was tethered to the firefly
reporter in control or FXR1 shRNA (FA4)-treated cells under serum-grown and -starved conditions.
(E) AGO2 is essential for translation upregulation mediated by tethered FXR1. lN-tagged FXR1 iso-a or the lN-tag vector was transfected with the
firefly reporter bearing 5B Boxes in control () or AGO2 shRNA (shAGO2)-treated cells under serum-grown and -starved conditions. Comparable
results were obtained with cells grown to saturation (quiescence).is necessary for translation activation or that FXR1 is re-
quired at a downstream step. Conversely, knockdown of
AGO2 decreased translation activation by tethered FXR1(Figure 6E). These data suggest that AGO2 and FXR1
function together to activate translation in response to
growth arrest.Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc. 1113
Figure 7. Serum Starvation Activates Translation by Relocalization of AGO2-Bound mRNPs to Polysomes
(A) Polysome profiles of extracts from (1) serum-grown or (2) serum-starved cells transfected with the TNFa ARE are shown.
(B) Western analysis of fractions across the profiles using antibodies against AGO2, FXR1, and PABC1 as a control is shown. FXR1 mobility becomes
heterogeneous (modifications or protein degradation) upon serum starvation. Since the lysates were clarified, the majority of FXR1 and AGO2 in
+serum are removed as large complexes, including those in large foci (Figures 5B and S7–S8), prior to gradient analysis (verified by the Extract lanes
marked +serum and serum).
(C) Anti-AGO2 (marked by brackets) and Y10B (arrows) immunoprecipitations were performed on the Free RNP (fractions 1–2), subunits (fractions
3–9, including monosomes), and polysomes (fractions 10–22), followed by western analyses using a-AGO2 and -FXR1 antibodies.
(D) RPA for the ARE-reporter RNA was performed on the pooled fraction as in (C).
(E) Western analysis of polysome profiles from serum-grown and -starved cells demonstrates a complete shift of AGO2 from polysomes (compare
with B,Serum lanes) to a single slowly sedimenting peak upon 1mMpuromycin treatment for 3 hr at 37C. Puromycin causes an equal proportion of
AGO2 to be clarified from extracts of both serum conditions.Serum Starvation Activates Translation
by Relocalization of AGO2-Bound mRNPs
to Heavy Polysomes
To demonstrate that the ARE-reporter RNA is bound by
AGO2 when recruited to polysomes in translation activa-
tion conditions, we performed sucrose gradient analyses
of soluble extracts from cells grown in serum or with se-
rum starvation (Figure 7). For two reasons, the cells were
not exposed to cycloheximide, a reagent commonly
used to freeze polysomes: Mazroui et al. (2002) showed
that FXR1 granules (Figure 5B) are disrupted by cyclohex-
imide, and Kedersha et al. (2005) observed a decrease in
P-body and stress-granule formation, which suggests that
cycloheximide may affect the normal distribution of
AGO2. We examined individual fractions from the gradi-
ents or pooled them into Free RNP (fractions 1–2), sub-
units (fractions 3–9), and polysomes (fractions 10–22)
and assessed the distribution of AGO2, FXR1, and the re-
porter RNA both with and without puromycin treatment.
Figure 7D (left panel) reveals that the TNFa ARE reporter
coimmunoprecipitated by anti-AGO2 indeed shifts down1114 Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Incin the gradient to concentrate in heavy polysomes in
serum-starved versus -grown cells. There is less AGO2
and FXR1 in the total profile (Figure 7B; Extract, compare
+ with  lanes) of serum-grown cells, likely due to the re-
moval of large complexes by clarification, as observed
earlier for FXR1 (Figure 4A); both proteins concentrate in
the Free RNP fractions (left panels). In serum-starved
cells, the amounts of AGO2 and FXR1 are higher, which
correlates with the absence of foci and the solubility of
FXR1 (Figure 4A). Figure 7C (upper and lower panels
marked by brackets) shows that FXR1 also coimmuno-
precipitates with anti-AGO2 in the polysome fraction of
serum-starved cells, while an antibody that interacts
with ribosomal RNA (Y10B; Lerner et al., 1981) confirms
that this AGO2 is ribosome associated (Figure 7C, ar-
rows). Puromycin treatment, which has been demon-
strated to increase both P bodies and stress granules (Ke-
dersha et al., 2005), released AGO2 from polysomes along
with collapsing the polysomes from both serum-starved
and -grown conditions (Figure 7E); note that the detection
of comparable low amounts of AGO2 suggests that an.
equal portion was clarified from extracts of serum-grown
versus -starved cells treated with puromycin. We con-
clude that the mechanism of translation activation by the
FXR1/AGO2 ARE complex involves recruitment of the
TNFa mRNP to heavy polysomes upon serum starvation.
DISCUSSION
We set out to elucidate how AREs regulate translation by
examining RNPs assembled in vivo on the TNFa ARE un-
der conditions where the translation output relative to
mRNA levels was enhanced. We first established that
the TNFa ARE—but not a mutant ARE—mediates upregu-
lation of translation efficiency upon serum starvation in re-
sponse to cell-cycle cues. Affinity purification surprisingly
revealed the presence of two proteins, FXR1 and AGO2,
which were previously considered to be repressive, in
the ARE-mRNP formed under serum-starved conditions.
Their interdependent translation stimulatory activity was
confirmed both by reducing their cellular levels and by
tethering them to a luciferase reporter in the absence of
the ARE. Our results underscore the versatility of RNA-
binding proteins in effecting both positive and negative
outcomes in response to different cellular environments.
The TNFa ARE Functions as a Translation
Upregulatory Element by Recruiting
FXR1 and AGO2
The ability of AREs to regulate both translation and mRNA
stability (Espel, 2005; Kontoyiannis et al., 1999) may result
primarily from differences in the signals received. How
might the TNFa ARE respond to such signals? Two possi-
ble molecular models exist: the ARE may recruit distinct
complexes to produce alternate outcomes or a common
ARE-binding complex may be modulated by the addition
or deletion of specific effectors. Our data support the latter
model since ARE-stability factors such as TTP and HuR
are present in all conditions, but FXR1 and AGO2 are re-
cruited only upon serum starvation (Figures 3C and 5C).
Recently, both HuR and TTP were implicated in mi-
croRNP-mediated translation repression through mRNA
relocalization into P bodies (Bhattacharyya et al., 2006)
or through interactions with AGO2 that induce mRNA
decay (Jing et al., 2005). HuR was further suggested to
be an agent alleviating microRNA-mediated repression
in a stress response to amino-acid starvation (Bhattachar-
yya et al., 2006). In contrast, we find that tethering HuR to
our 5B Box reporter increases translation efficiency less
than 2-fold (Figure S9), arguing that the upregulation
studied here is distinct. Only upon serum starvation
does FXR1 interaction with AGO2 remodel the ARE com-
plex to enhance rather than repress translation (Figures
6A, 6D, and 6E; Jin et al., 2004).
FXR1 Is a Cell-Cycle-Sensitive Translation Regulator
Since translation activation can be achieved either by se-
rum starvation leading to FXR1 association with the ARE
or by tethering FXR1 to themRNA (Figures 3–4), mRNA as-Csociation may be the decisive switch that converts FXR1
into a translation activator. The ability of FXR1 to associate
with the TNFa ARE (Garnon et al., 2005) could be regu-
lated by either its modification or that of other ARE-bound
factors. Exogenous expression of FXR1, which—like teth-
ering—activates translation irrespective of the signals
present (Figure 4C), correlates with an increase in soluble
FXR1 (Figures 4C, lower panel, and 4F). Thus, FXR1 solu-
bility may be critical in altering the translation outcome in
response to serum starvation.
In serum-grown cells, FXR1 appears in cytoplasmic
bodies (Figures 5B and S7–S8) that are reported to be as-
sociated with translation silencing (Mazroui et al., 2002;
Hofmann et al., 2006). The nature of these bodies is cur-
rently unclear, but it seems unlikely that they are P bodies
because they do not completely colocalize with the P-
body marker hDCP1A (Figures S7F and S7G). Although
P bodies and GW bodies overlap and have been consid-
ered the same bodies, there is growing evidence for dis-
tinct subsets (Eystathioy et al., 2003). GW bodies are
cell-cycle-regulated and disappear on growth arrest
(Yang et al., 2004; Lian et al., 2006), as we observe for
FXR1 bodies (Figures 5B and S8, compare +serum with
serum), while P bodies remain (Figure S7G). Interest-
ingly, AGO proteins were recently shown to colocalize
with GW bodies in a similar cell-cycle-regulated manner
(Ikeda et al., 2006).
Under serum-grown conditions, FXR1 may function as
a translation repressor through its interaction with AGO
proteins (Figure 5A; Liu et al., 2005a; Caudy et al., 2002).
Indeed, macrophages from FXR1 knockout mice exhibit
increased translation of a TNFa ARE reporter when
compared to those from wild-type mice (Garnon et al.,
2005).
AGO2 Activates Translation in Response
to Serum Starvation
AGO2 (also called eIF2C2) was originally identified as an
enhancer of in vitro translation through stimulation of
ternary complex formation and stability (Zou et al., 1998;
Roy et al., 1988). Aubergine, a Drosophila member of the
PIWI subfamily of Argonaute-related proteins, is a transla-
tion repressor and RNAi factor during early oogenesis but
later acts as a translation activator (Wilhelm and Smibert,
2005). Tethering AGO2 yields a moderate 1.8-fold repres-
sion in HEK293 cells in serum-grown conditions (Fig-
ure 6A), which is similar to observations in HeLa cells
(Liu et al., 2005b). Up to 5-fold repression was reported
by Pillai et al. (2004), but using 5-fold more AGO2 plasmid
and the transfection reagent Lipofectamine, which has re-
cently been observed to induce toxicity and alter expres-
sion (unpublished data; Barreau et al., 2006).
Tethering AGO2, unlike FXR1, upregulates translation
only in the absence of serum (Figure 6A), which suggests
that AGO recruitment to the mRNA is not the step that
decides outcome. Since AGO2 tethering failed to activate
translation in an FXR1 knockdown background (Figure 6D)
and vice versa (Figure 6E), interaction between FXR1 andell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc. 1115
AGO2 (direct or indirect) is required for translation activa-
tion.
FXR1 and AGO2 associate with cytoplasmic foci that
partially colocalize in serum-grown conditions (Figures
5B and S7A–S7C). Under serum-starvation conditions,
where AGO2 and FXR1 become bound to the ARE-
containing message (Figures 3C and 5C–5D), they are
more diffusely present in the cytoplasm or in smaller foci,
which possibly accounts for their transformation into transla-
tion upregulatory effectors (Figures 5B, Serum panels,
S7D, S7E, S7G, and S8, lower panels of A, B, and D).
Jing et al. (2005) previously demonstrated that AGO2 in-
teracts with TTP and miR16-1 to induce decay of a TNFa
30-UTR reporter mRNA. The interaction involved an AU-
rich nonamer present elsewhere in the TNFa 30-UTR, not
the canonical 34 nt ARE studied here. We confirmed that
their complex is distinct in that miR16 does not associate
specifically with our ARE mRNP (Figure S10A), nor does
miR16 knockdown affect translation (Figures S10B and
S10C). The involvement of a microRNA in translation acti-
vation remains to be explored. Our data indicate that
AGO2, like FXR1, plays a dual role on the TNFa 30-UTR
and exerts translation regulation through the ARE or
microRNA-mediated decay through a distinct 30-UTR
element (Jing et al., 2005).
Mechanism of ARE-Mediated Translation Regulation
Polysome profile analyses of soluble cytoplasmic extracts
revealed that translation upregulation correlates with
a shift of the FXR1/AGO2 ARE mRNP complex from the
free/subunit fractions to heavier polysomes (Figures 7B–
7E) upon serum starvation. In this condition, most of the
AGO2 and FXR1 appear diffuse or are present in small
foci (Figure 5B) that sediment to the bottom of the gradi-
ent. Conversely, in serum-grown cells, most FXR1 and
AGO2 are removed by extract clarification (demonstrated
by the Extract lanes, Figure 7B), presumably because they
exist in larger insoluble complexes that include the foci ob-
served in Figures 5B and S7–S8. The polysome experi-
ments (Figure 7) were performed without agents, like cy-
cloheximide, that appear to disrupt or diminish these
foci (Mazroui et al., 2002; Kedersha et al., 2005) and might
alter AGO2 localization. In contrast, recent studies dem-
onstrate AGO proteins andmicroRNP complexes on poly-
somes in growing cells (Nelson et al., 2004; Nottrott et al.,
2006; Maroney et al., 2006) using cycloheximide or eme-
tine. Our results suggest that growth arrest decreases
GW/FXR1/AGO2 foci and promotes ARE-specific poly-
some association of the AGO2-bound mRNP complex.
The molecular basis for transformation of the ARE
mRNP into a translation activator complex that enables
upregulated expression of cytokine messages such as
TNFa remains to be elucidated.
EXPERIMENTAL PROCEDURES
For detailed procedures see Supplemental Data.1116 Cell 128, 1105–1118, March 23, 2007 ª2007 Elsevier Inc.Cell Culture
HEK293 cells and THP-1 monocytes that were maintained in DMEM or
RPMI, respectively, with 10% FBS were transfected with Trans-It 293
kit (MirusBio) for HEK293 or Nucleofector (Amaxa) for THP-1 per the
manufacturer’s instructions.
Extract Preparation and Purification of S1-Tagged mRNP
Cells transfected with the S1-tagged constructs and grown in various
serum conditions (Figure 3) were incubated with 0.2% formaldehyde in
PBS for 10 min at 37C (Niranjanakumari et al., 2002). Cells were lysed
(150 mM KCl, 10 mM Hepes 7.4, 3 mM MgCl2, 2 mM DTT, 10% glyc-
erol, and 0.5%NP-40) for 10min on ice, sonicated and clarified by cen-
trifugation at 2000 g for 5 min, precleared with avidin beads, followed
by DEAE sepharose fractionation (150–1000 mM KCl). The 1 M frac-
tion, which was enriched for the firefly RNA, was then bound to strep-
tavidin for 4 hr; washed ten times with a salt gradient up to 300mMKCl
in the binding buffer with tRNA, glycogen, and 2% NP-40; and eluted
for 1 hr with 5 mM biotin (Srisawat and Engelke, 2002). After heat inac-
tivation at 65C for 45 min (Niranjanakumari et al., 2002), the RNA and
proteins were assayed.
Immunofluorescence
Laser-scanning confocal immunofluorescence imaging was per-
formed using an inverted Axiovert 200 LSM 510 Meta confocal micro-
scope (Zeiss) at the Yale Cell and Confocal Microscopy and Imaging
Facility. Briefly, cells were fixed with 2% formaldehyde, permeabilized
with methanol or 0.1% Tween 20, blocked, incubated, and washed
with 1% normal goat serum in PBS.
RNA Analyses
Northern blots were performed on 10 mg total RNA, run on a 1% form-
aldehyde gel, and probed with 32P-labeled RNAs complementary to
the 30 end of the coding region of firefly (330 nt from the stop codon)
or ofRenilla (90 nt from the stop codon; Figure 1). For all other figures,
RPA was performed using the same probes, and the protected sam-
ples were run on 6% PAGE, dried, and quantitated by a Storm 840
phosphorimager (Molecular Dynamics).
Translation Assays
Luciferase activities weremeasured using a TD 20/20n (Turner BioSys-
tems) and the Dual Luciferase Assay System (Promega) per manufac-
turers’ instructions. The firefly to Renilla luciferase ratio was further
normalized for RNA levels (see Figures 1A and S1; Tables S1–S3).
Polysome analysis was performed as described in Ceman et al.
(2003).
Supplemental Data
Supplemental Data include ten figures, four tables, Experimental Pro-
cedures, and References and can be found with this article online at
http://www.cell.com/cgi/content/full/128/6/1105/DC1/.
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